Hola,
Are you new here?

RHYTHM IN DEMENTIA

financed

Circadian rhythm: from preclinical to post-diagnosis dementia

Circadian rhythm (CR) regulates body functions over the 24-hour day/night period; sleep/wake cycle is its most visible manifestation. CR disruptions have long been observed in patients with dementia and emerging evidence points to... see more

30/04/2028

INSERM

2M€

Project Budget: 2M€

Project leader

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

PARTICIPATION DEPralty Sin fecha límite de participación.

Ver 2 Participantes

Financing granted El organismo HORIZON EUROPE notifico la concesión del proyecto The day 2022-12-02

ERC-2021-COG: ERC CONSOLIDATOR GRANTS Scope:Objectives

I+D

Cerrada

0% 100%

characteristics of the participant

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Private Information

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

INSERM

1.61M€ | Leader

ASSISTANCE PUBLIQUE HOPITAUX...

389.85K€ | participant

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Project duration: 64 months Date Start: 2022-12-02
End date: 2028-04-30

Project leader

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHER... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Project Budget 2M€

participation deadline Sin fecha límite de participación.

Project description Circadian rhythm (CR) regulates body functions over the 24-hour day/night period; sleep/wake cycle is its most visible manifestation. CR disruptions have long been observed in patients with dementia and emerging evidence points to their presence in the preclinical period of dementia. This suggests that certain aspects of CR could be useful in identification of high-risk individuals and could serve as potential targets for interventions to delay dementia onset and progression. This requires an in-depth understanding of the role of CR in dementia pathogenesis. As population ageing increases dementia burden, it is critical to find strategies to identify patients at risk of dementia with precision, prevent, and slow its progression. Building on recent advances in accelerometery (to assess CR features comprehensively) and dementia biomarkers (deep-phenotyping of dementia pathogenesis), RHYTHM IN DEMENTIA will make a decisive step-change in knowledge by determining CR features involved in dementia processes along the course of the disease. The aims are: 1) identify core CR features that shape 10-year risk of dementia in a community-dwelling cohort of 4000 older adults; 2) uncover specific CR disruptions that characterise major dementia subtypes and stages of Alzheimer’s disease (determined by biomarkers) in a new cohort of 1500 patients recruited from two memory clinics in Paris; and 3) ascertain how CR affects dementia prognosis in the patient cohort by examining cognitive and functional decline, hospitalisation, institutionalisation, and mortality. This project will yield new insight into the nature of the association between CR and dementia progression. These findings will ultimately inform the potential for a cost-effective and easy to use tool to assess CR features to facilitate both identification of patients at risk of dementia and tailored secondary prevention interventions that address CR disruptions in dementia patients and slow progression of dementia.

Conecta tu I+D

Entra hoy

Forgot your password?

Financing

Companies

CTIs/Universidades

Projects

researchers